Myocarditis is usually caused by viruses, e.g. in COVID-19 disease. However, it can also be induced by medication, toxic substances or in the context of a rheumatological disease. Clinical assessment is difficult due to widely varying symptom. The researchers' objective is to develop evaluation tools that can be used to determine whether myocarditis will heal spontaneously and sustainably or whether close monitoring is needed.
Researchers supported by the EU-funded ConcePTION project are helping to reduce uncertainty about the safety of medicines used by expectant and breastfeeding mothers. Their new study contributes to the development of a system that can transform existing healthcare data into evidence in a robust and transparent way. This will help to answer questions about medicine use, effectiveness and safety during pregnancy and breastfeeding.
The EC has approved under EU State aid rules Spain's map for granting regional aid within the framework of the revised Regional aid Guidelines ('RAG'). The revised RAG, enable Member States to support the least favoured European regions in catching up and to reduce disparities in terms of economic well-being, income and unemployment. They also provide increased possibilities to support regions facing transition or structural challenges such as depopulation, to contribute fully to the green and digital transitions.
The number of people being diagnosed with cancer by 2040 in EU and EFTA countries is estimated to increase by 21% compared to 2020, according to the Joint Research Centre (JRC) experts who studied the impact of population aging on the future cancer burden. The experts also estimate that population ageing will lead to a big increase in the number of people dying from cancer of 32% by 2040, compared to 2020.
The European Investment Fund (EIF) and Resilience Partners, a private debt firm, have partnered to provide financing support and flexibility to high-growth Spanish and European SMEs. In view of the large demand from companies with financial needs, the Resilience Partners Fund II, S.C.A., SICAR has achieved a first close and expects to mobilise a total of €150-200 million in financing to these companies.
An artificial intelligence (AI) tool can accurately and consistently classify breast density on mammograms, according to a study in Radiology: Artificial Intelligence. Breast density reflects the amount of fibroglandular tissue in the breast commonly seen on mammograms. High breast density is an independent breast cancer risk factor, and its masking effect of underlying lesions reduces the sensitivity of mammography.
The European Commission had proposed on 3 February 2022 to extend the Regulation establishing the EU Digital COVID Certificate by one year, until 30 June 2023. It had also introduced other targeted amendments to extend the range of authorised antigen tests and to allow vaccination certificates to be issued to persons participating in clinical trials, for example.
The Commission has approved the disbursement of more than €2 billion under the Brexit Adjustment Reserve to a group of 12 Member States. This decision will make available a total of €819.2 million by the end of March 2022 and the rest by April 2023. This funding will help the economies of the Member States in mitigating the adverse impact of Brexit on their economies and regions, through support to regions and economic sectors, small and medium sized companies as well as job creation and protection, such as short-time work schemes, re-skilling, and training.
The Commission approved 225 projects under the Technical Support Instrument (TSI), to support Member States in preparing, designing and implementing reforms that will lead to modern and resilient public administrations, sustainable growth strategies and resilient economies while enhancing their capacity to react to current and future crises. The 2022 TSI Work Programme also includes some novelties like the multi-country or multi-region projects, as well as the flagship projects.
More than 1 in 7 adults in Europe experience a high-pitched ringing in the ears called tinnitus, according to a recent study supported by the EU-funded ESIT, UNITI and GENDER NET Plus projects. The current study is most likely the first of its kind to have collected multinational data on tinnitus using the same standardised survey questions and response options across 12 European countries.
The European Liquid Biopsy Society, an offshoot of the IMI project CANCER-ID, is pushing the science on liquid biopsies closer to clinical reality. The ability to detect and study tumours through a mere blood sample – a minimally invasive procedure – would have huge implications, and a lot of progress has been made in the development of different technologies that achieve this ambitious goal.
The Innovative Medicines Initiative’s European Lead Factory, a screening service with a vast chemical library, has helped identify two drug candidates for cancer treatment that have now progressed to clinical testing. An Israeli SME called Metabomed and the German pharmaceutical company Merck KGaA, have both recently identified compounds in ELF’s high-quality compound collection that show promise in inhibiting their target pathways, both of which are involved in the development of tumours.